Achievement of renal anemia KDIGO targets by two different clinical strategies – a European hemodialysis multicenter analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Achievement of renal anemia KDIGO targets by two different clinical strategies – a European hemodialysis multicenter analysis ; volume:20 ; number:1 ; day:7 ; month:1 ; year:2019 ; pages:1-10 ; date:12.2019
BMC nephrology ; 20, Heft 1 (7.1.2019), 1-10, 12.2019
- Urheber
-
Drozdz, Maciej
Weigert, André
Silva, Fatima
Frazão, João
Alsuwaida, Abdulkareem
Krishnan, Mahesh
Kleophas, Werner
Brzosko, Szymon
Johansson, Fredrik K.
Jacobson, Stefan H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-018-1196-7
- URN
-
urn:nbn:de:101:1-2019021101534157920317
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Drozdz, Maciej
- Weigert, André
- Silva, Fatima
- Frazão, João
- Alsuwaida, Abdulkareem
- Krishnan, Mahesh
- Kleophas, Werner
- Brzosko, Szymon
- Johansson, Fredrik K.
- Jacobson, Stefan H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement
Cardio renal anemia syndrome
Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis
Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients
Hemodialysis patients’ preferences for the management of anemia
A multicenter descriptive analysis of anemia management in hemodialysis patients and its association with quality of life
Adequate hemodialysis improves anemia by enhancing glucose-6-phosphate dehydrogenase activity in patients with end-stage renal disease
Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients
Trends in anemia management in US hemodialysis patients 2004–2010
Optimizing anemia management using artificial intelligence for patients undergoing hemodialysis
Management guidelines for the treatment of renal anemia
Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement
Cardio renal anemia syndrome
Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis
Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients
Hemodialysis patients’ preferences for the management of anemia
A multicenter descriptive analysis of anemia management in hemodialysis patients and its association with quality of life
Adequate hemodialysis improves anemia by enhancing glucose-6-phosphate dehydrogenase activity in patients with end-stage renal disease
Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients
Trends in anemia management in US hemodialysis patients 2004–2010
Optimizing anemia management using artificial intelligence for patients undergoing hemodialysis
Management guidelines for the treatment of renal anemia
Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement
Cardio renal anemia syndrome
Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis
Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients
Hemodialysis patients’ preferences for the management of anemia
A multicenter descriptive analysis of anemia management in hemodialysis patients and its association with quality of life
Adequate hemodialysis improves anemia by enhancing glucose-6-phosphate dehydrogenase activity in patients with end-stage renal disease
Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients
Trends in anemia management in US hemodialysis patients 2004–2010
Optimizing anemia management using artificial intelligence for patients undergoing hemodialysis
Management guidelines for the treatment of renal anemia